- Vouliez-vous dire
- virus vaccines
Résultats de la recherche - 14 results
Surveillance des infections respiratoires aiguës: rapport épidémiologique saisons 2022-2023 et 2023-2024
Epidemiologie van infectieziekten Epidemiology of infectious diseases Étude des soins de santé Gezondheidszorgonderzoek Health services research Maladies virales Virale ziekten Viral diseases Manuscript ...
Surveillance van acute luchtweginfecties: epidemiologisch rapport seizoenen 2022-2023 en 2023-2024
infectious diseases Étude des soins de santé Gezondheidszorgonderzoek Health services research Maladies virales Virale ziekten Viral diseases Manuscript versions: DOI: https://doi.org/10.25608/jeb0-4n04 ...
Bulletin infections respiratoires aiguës semaine 36-2025- Publié 10/09/25
Respiratoir syncytieel virus (RSV) Service: Épidémiologie des maladies infectieuses Epidemiologie van infectieziekten Epidemiology of infectious diseases Maladies virales Virale ziekten Viral diseases Étude ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Van Loon; Katelijne Dierick; André Matagne; I Desombere; Ariën, Kevin K; Arnaud Marchant; Maria Goossens Source: Vaccine, Volume 41, Issue 17 (2023) Keywords: Adult Antibodies, Viral BNT162 Vaccine ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)
2 (27/09-24/10) the percentage of adults (18 years or older) with anti- SARS-CoV-2 antibodies has increased from 69.5% to 90.4%. This substantial increase is in line with the intensive vaccination campaign during ...
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study
period, which coincided with the onset of the vaccination campaign, the seroprevalence in the population increased from 25.2% in March/April to 78.1% in July. Among the vaccinated there was an increase from ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study
community dwelling population aged 18 years and above had developed anti- SARS-CoV-2 antibodies. This percentage was 98.9% among fully vaccinated people (since at least 2 weeks before being tested) and 28.9% ...
Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT-qPCR Assays in the Context of New Variants
COVID-19 diagnosis is the detection of viral RNA by RT-qPCR with a specific set of primers and probe. It is important to frequently evaluate the performance of these tests and this can be done first by an in ...
Use of Whole Genome Sequencing Data for a First in Silico Specificity Evaluation of the RT-qPCR Assays Used for SARS-CoV-2 Detection.
Keersmaecker Source: Int J Mol Sci, Volume 21, Issue 15 (2020) Keywords: Betacoronavirus Coronavirus Infections Databases, Genetic Genome, Viral Humans Open Reading Frames Pandemics Pneumonia, Viral ...
Towards a European strategy to address the COVID-19 pandemic.
Europe HEALTH POLICY Humans incidence Mass Vaccination Pandemics Physical Distancing SARS-CoV-2 Health Topics: Coronavirus Coronavirus Coronavirus Service: Maladies virales Virale ziekten Viral diseases ...